Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Leuk Lymphoma ; 54(12): 2720-7, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23547841

RESUMO

Myelodysplastic syndromes (MDS) are a group of hematopoietic malignancies characterized by ineffective hematopoiesis. Recently, we identified MDS-associated microRNAs (miRNAs) that are down-regulated in MDS. This study examines possible explanations for that observed down-regulation of miRNA expression in MDS. Since genomic losses are insufficient to explain the down-regulation of all our MDS-associated miRNAs, we explored other avenues. We demonstrate that these miRNAs are predominantly intragenic, and that, in many cases, they and their host genes are expressed in a similar pattern during myeloid maturation, suggesting their co-regulation. This co-regulation is further supported by the down-regulation of several of the host genes in MDS and increased methylation of the shared promoters of several miRNAs and their respective host genes. These studies identify a role of hypermethylation of miRNA promoters in the down-regulation of MDS-associated miRNAs, unifying research on miRNAs in MDS and epigenetic regulation in MDS into a common pathway.


Assuntos
Metilação de DNA , Regulação da Expressão Gênica , MicroRNAs/genética , Síndromes Mielodisplásicas/genética , Regiões Promotoras Genéticas , Diferenciação Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Deleção Cromossômica , Mapeamento Cromossômico , Ilhas de CpG , Regulação da Expressão Gênica/efeitos dos fármacos , Humanos , MicroRNAs/metabolismo , Transcriptoma , Tretinoína/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...